More potent inhibition of human CYP2A6 than mouse CYP2A5 enzyme activities by derivatives of phenylethylamine and benzaldehyde

By Rahnasto M.   Raunio H.   Poso A.   Juvonen R. O.  

Xenobiotica, Vol. 33, Iss. 5, 2003-01 ,pp. : 529-539

Informa Healthcare

Access to resources Recommend Favorite

CYP2A13-catalysed coumarin metabolism: comparison with CYP2A5 and CYP2A6

By VON WEYMARN L. B.   MURPHY S. E.  

Xenobiotica, Vol. 33, Iss. 1, 2003-01 ,pp. : 73-81

Informa Healthcare

Access to resources Recommend Favorite

Species differences in coumarin metabolism: a molecular modelling evaluation of CYP2A interactions

By Lewis D. F. V.   Lake B. G.  

Xenobiotica, Vol. 32, Iss. 7, 2002-07 ,pp. : 547-561

Informa Healthcare

Access to resources Recommend Favorite

Molecular modelling of CYP2B6, the human CYP2B isoform, by homology with the substrate-bound CYP102 crystal structure: evaluation of CYP2B6 substrate characteristics, the cytochrome b5 binding site and comparisons with CYP2B1 and CYP2B4

By Lewis D. F. V.   Lake B. G.   P. M. Dickins   Eddershaw J.   Tarbit M. H.   Goldfarb P. S.  

Xenobiotica, Vol. 29, Iss. 4, 1999-04 ,pp. : 361-393

Informa Healthcare

Access to resources Recommend Favorite

Quantitative structure-activity relationships within a homologous series of 7-alkoxyresorufins exhibiting activity towards CYP1A and CYP2B enzymes: molecular modelling studies on key members of the resorufin series with CYP2C5-derived models of human CYP1A1, CYP1A2, CYP2B6 and CYP3A4

By Lewis David F. V.   Lake Brian G.   Dickins M.  

Xenobiotica, Vol. 34, Iss. 6, 2004-06 ,pp. : 501-513

Informa Healthcare

Access to resources Recommend Favorite